Harmony Biosciences
Price & Volume
Stats
See more52W Range | $25.52-$40.87 |
Market Cap | $1.7B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $899.1M |
Revenue Growth (YoY) | 16.6% |
Gross Profit (12 Mos) | $688.2M |
Diluted EPS | $2.48 |
News
See moreYahoo Finance • last month
Humana and Thor Hit the Casualty List
Yahoo Finance • 2 months ago
Truist Securities Downgrades Harmony Biosciences Holdings, Inc. (HRMY) to Hold After Patent Trial Developments
Yahoo Finance • 3 months ago
Harmony Biosciences tumbles following Deutsche Bank, Truist downgrades
Yahoo Finance • 5 months ago
Harmony Biosciences To Present New Data From Phase 3 Trial Of EPX-100 In Dravet Syndrome Next Week
About
CEO | Dr. Jeffrey M. Dayno M.D. |
Address | 630 West Germantown Pike, Plymouth Meeting, PA, United States, 19462 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 293 |